🇺🇸 FDA
Patent

US 11885817

Biomarkers and methods for detection of seizures and epilepsy

granted A61PA61P25/08

Quick answer

US patent 11885817 (Biomarkers and methods for detection of seizures and epilepsy) held by Cognizance Biomarkers, LLC expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Cognizance Biomarkers, LLC
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P25/08